Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · IEX Real-Time Price · USD
2.970
+0.070 (2.41%)
At close: Apr 22, 2024, 4:00 PM
2.980
+0.010 (0.34%)
After-hours: Apr 22, 2024, 5:25 PM EDT

Organogenesis Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Revenue
433.14450.89467.36338.3260.98193.45198.51138.73
Revenue Growth (YoY)
-3.94%-3.52%38.15%29.63%34.91%-2.55%43.09%-
Cost of Revenue
106.48105.02114.287.3275.9568.8161.2248.2
Gross Profit
326.66345.87353.16250.98185.03124.64137.2990.53
Selling, General & Admin
269.75283.81250.2204.19200.09161.96133.7293.03
Research & Development
44.3839.7630.7420.0914.810.749.076.28
Other Operating Expenses
00000-0.160.010
Operating Expenses
314.13323.57280.94224.28214.89172.54142.7999.31
Operating Income
12.5322.372.2226.7-29.85-47.9-5.5-8.78
Interest Expense / Income
2.192.017.2411.28910.798.015.63
Other Expense / Income
-0.060.011.9-2.34-0.296.061.92.52
Pretax Income
10.3920.2863.0917.76-38.56-64.75-15.41-16.92
Income Tax
5.454.75-31.120.530.150.08-7.030.07
Net Income
4.9515.5394.217.23-38.71-64.83-8.39-16.99
Preferred Dividends
00000.5700.420
Net Income Common
4.9515.5394.217.23-39.28-64.83-8.81-16.99
Net Income Growth
-68.16%-83.51%446.61%-----
Shares Outstanding (Basic)
13113012810893696463
Shares Outstanding (Diluted)
13313213411193696463
Shares Change
0.27%-0.96%20.03%19.95%33.93%8.52%1.08%-
EPS (Basic)
0.040.120.730.16-0.42-0.94-0.14-0.27
EPS (Diluted)
0.040.120.700.15-0.42-0.94-0.14-0.27
EPS Growth
-66.67%-82.86%366.67%-----
Free Cash Flow
6.55-9.0430.76-12.21-39.76-62.49-5.91-6.12
Free Cash Flow Per Share
0.05-0.070.24-0.11-0.43-0.90-0.09-0.10
Gross Margin
75.42%76.71%75.57%74.19%70.90%64.43%69.16%65.26%
Operating Margin
2.89%4.95%15.45%7.89%-11.44%-24.76%-2.77%-6.33%
Profit Margin
1.14%3.44%20.16%5.09%-15.05%-33.51%-4.44%-12.24%
Free Cash Flow Margin
1.51%-2.00%6.58%-3.61%-15.24%-32.30%-2.98%-4.41%
Effective Tax Rate
52.42%23.42%-49.32%2.98%----
EBITDA
36.0340.328737.23-19.74-46.98-1.78-3.98
EBITDA Margin
8.32%8.94%18.61%11.00%-7.56%-24.29%-0.89%-2.87%
Depreciation & Amortization
23.4518.0316.688.189.836.985.637.32
EBIT
12.5822.2970.3229.04-29.56-53.96-7.4-11.3
EBIT Margin
2.90%4.94%15.05%8.59%-11.33%-27.89%-3.73%-8.14%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).